Begin typing your search above and press return to search.
Schools breeding hatred
access_time 14 Sep 2023 10:37 AM GMT
access_time 16 Aug 2023 5:46 AM GMT
May that spark not be extinguished
access_time 2 Dec 2023 8:55 AM GMT
A Constitution always in the making
access_time 27 Nov 2023 11:43 AM GMT
Debunking myth of Israel’s existence
access_time 23 Oct 2023 7:01 AM GMT
Homechevron_rightLifestylechevron_rightHealthchevron_rightPetition to declare...

Petition to declare Covishield unsafe; Madras HC sends Centre notice

Petition to declare Covishield unsafe; Madras HC sends Centre notice

Madras High Court today issued a notice to the Central government over a writ petition filed by Asif Riaz from Chennai, who had volunteered for the third phase of Covishield vaccine to declare the vaccine prepared by Serum Institute of India, Pune, as unsafe. Covishield, created in partnership with Oxford University and AstraZeneca, was cleared last month for emergency use together with Covaxin.

41-year-old Asif claims to have faced no side effects in the first ten days of receiving the trial from Sri Ramachandra Institute of Higher Education and Research. However, on the eleventh day, October 11, 2020, he allegedly developed a severe headache and had to be hospitalised for 16 days.

"I am still not stable, as I often experience trembling of hands, fear, anxiety, trepidation, panic, mood swings, and extreme problems in focusing on work..." stated Asif in the petition. The petition goes on to request the central government and the ICMR not to approve the vaccine.

However, SII hit back with a 100 crores defamation suit for 'maligning the company'. "The volunteer was specifically informed by the medical team that the complications he suffered were independent of the vaccine trial he underwent. In spite of specifically being made aware of the same, he still chose to go public and malign the reputation of the company," the company said in a statement.

The DCGI had also reasserted the safety of the vaccine. "We'll never approve anything if there is slightest of safety concern. The vaccines are 110 per cent safe. Some side effects like mild fever, pain and allergy are common for every vaccine," the Drug Controller General of India VG Somani had said.

However, the petitioner has alleged in court that the expert committee formed independently by the DCI had submitted its report without examining him and demanded the court to form an expert committee to study the issue. He has also appealed to the court to grant an interim order restraining the administration of Covishied until the disposal of the petition.

Justice Abdul Qudhose admitted the plea and sent notices to the Centre, DCGI and ICMR to file a detailed report by March 26. Meanwhile, over one crore vaccines have been administered since the vaccination drive began on January 16.

Show Full Article
TAGS:vaccine trialsOxfordAstraZenecaCovishield
Next Story